Comparative effectiveness of heterologous and homologous primary- and booster SARS-CoV-2 vaccination schedules in the Nordic countries

First published 05/04/2022

Last updated 23/04/2024

EU PAS number:

EUPAS46537

Study

Finalised

Download as PDF

Documents

Study protocol

Initial protocol

EMA_CVE_STUDYPROTOCOL_final_v1_

English (1.18 MB - PDF)View document

Updated protocol

EMA_CVE_STUDYPROTOCOL_v1_1

First published: 22/02/2024

English (1.19 MB - PDF)View document

Study results

Study results

EMA_CVE_study_report_240822-1-92

English (5.78 MB - PDF)View document

Study report

Study report

EMA_CVE_study_report_240822-93-219

English (7 MB - PDF)View document

Other information

ENCePP Seal

ENCePP Seal documents